Near‐Infrared Conjugated Macrocyclic BODIPYs for Photothermal Cancer Therapy
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202511125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Fei Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioresources and Materials Engineering, Shaanxi Collaborative Innovation Center of Industrial Auxiliary Chemistry & Technology, Shaanxi Un…. Hauptthemen laut MEDLINE: Boron Compounds, Antineoplastic Agents, Photothermal Therapy, Photosensitizing Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shaanxi Province Technology Innovation Guidance Project, Qin Chuang-yuan Team Construction Project of Shaanxi Science and Technology Department.
Abstract (Originalsprache)
With this research we developed a cyclization strategy that effectively converts radiative transitions (RTs) to non‐radiative transitions (NRTs) during the decay process of BODIPY‐based photosensitizers. Compared to BODIPY monomers, cyclization leads to a significant decrease in the HOMO–LUMO energy gap and a significant increase in the HOMO energy. In particular, the absorption spectrum of 7a exhibits a significant redshift, with the maximum absorption wavelength reaching 794 nm. Photophysical characterization indicates that the macrocyclic BODIPY derivatives 7(a–d) exhibit a reduced RT process. While, the crystal structure and theoretical calculations suggest that the molecular ring distortion enhances the intersystem crossing (ISC) ability of the macrocyclic BODIPY derivatives 7(a–d) . In addition 7a‐NPs constructed using DSPE‐mPEG 2000 encapsulation exhibit excellent water solubility, stability, and photothermal conversion efficiency (44.6%). The photothermal therapeutic performance of 7a‐NPs was evaluated through in vitro cell and in vivo mice experiments. The results indicated that 7a‐NPs could be enriched at the tumor site and exhibited strong tumor ablation ability using near‐infrared radiation. Our findings suggest that the regulation of the RT to NRT conversion using an alkali‐induced cyclization reaction is a useful strategy for preparing efficient photo‐thermal conversion materials based on BODIPY.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Bioresources and Materials Engineering, Shaanxi Collaborative Innovation Center of Industrial Auxiliary Chemistry & Technology, Shaanxi University of Science & Technology, Xi'an, 710021, China.
- College of Pharmacy, Xi'an Medical University, Xi'an, 710021, China.
- Department of Chemistry, University of Bath, Bath, BA27AY, United Kingdoms.
- School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, 453007, China.
ORCID-Profile: Fei Cheng, Taotao Qiang, Tony D James
Förderung
- National Natural Science Foundation of China
- Shaanxi Province Technology Innovation Guidance Project
- Qin Chuang-yuan Team Construction Project of Shaanxi Science and Technology Department
- Shaanxi Province Outstanding Youth Science Foundation Project
- School of Chemistry and Chemical Engineering, Henan Normal University
Zitieren
APA
Cheng, F., Qiang, T., Li, M., Li, R., Wang, Z., & James, T. D. (2025). Near‐Infrared Conjugated Macrocyclic BODIPYs for Photothermal Cancer Therapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202511125
Vancouver
Cheng F, Qiang T, Li M, Li R, Wang Z, James TD. Near‐Infrared Conjugated Macrocyclic BODIPYs for Photothermal Cancer Therapy. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202511125
BibTeX
@article{Cheng2025,
author = {Cheng, Fei and Qiang, Taotao and Li, Mingli and Li, Ruilong and Wang, Zhigao and James, Tony D},
title = {Near‐Infrared Conjugated Macrocyclic BODIPYs for Photothermal Cancer Therapy},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202511125}
}
EUVIMED